Influenza A H1N1 Virus

1808 Words4 Pages

Introduction

In 1918-19 approximately 50 million deaths were a detriment of the Spanish H1N1 virus pandemic; a respiratory virus. According to the World Health Organization, the second Influenza A H1N1 pandemic in 2009 spread to more than 200 countries causing more than 18 000 deaths. Before the World Health Organization had announced the official end of the pandemic in August 2010, in July 2009 the World Health Organization sent out a phase 6 warning that H1N1 could soon be a global pandemic. It is important to recognize that the 2 different outbreaks had different A/H1N1strains effecting the world population; this suggests A/H1N1has a high ability for mutation, severely complicating the human body’s natural immune mechanism of antigenic drift. (Qi-Shi Du et al., 2010)

Epidemiology

According to the Swine flu investigation team on April 15 and April 17, 2009, novel swine-origin influenza A (H1N1) virus (S-OIV) was isolated from two epidemiologically unlinked patients in the United States. The same strain was identified in other countries such as Mexico and Canada. In the United States 60% of patients were 18 years of age or younger suggesting that the younger population was more susceptible to the transmission of S-OIV or the possibility that the older population had developed a small amount of antibodies from the 1976 swine influenza vaccine (H1N1). 18% of the patients had recently traveled to Mexico, and 16% were identified from school outbreaks. (France, Jackson & Schrag, 2010) The most common presenting symptoms were fever (94% of patients), cough (92%), and sore throat (66%); 25% of patients had diarrhea, and 25% were experiencing emesis. Therefore, the criteria characterizing the S-OIV infection are comparable to the ...

... middle of paper ...

... S.M., My Yang, Halvorson, D.A & Sreevatsan, S. (2009) The Feasibility of Using High

Resolution Genome Sequencing of Influenza A Viruses to Detect Mixed Infections and

Quasispecies. PLoS One 4(9), 7105.

Thorlund K, Awad T, Boivin G, Thabane L. Systematic review of influenza resistance to the

neuraminidase inhibitors. BMC Infect Dis 2011;11:134.

Vries, E.V.D., Schutten, M & Boucher, C.A.B. (2010) The potential for multidrug-resistant

influenza. New England Journal of Medicine 24, 599–604.

Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. (2009) Medical Progress Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

Gambaryan A. S & Matrosovich M. N.(1992) A solid- phase enzyme-linked assay for influenza

virus receptor binding activity. Journal of Virology 39, 111–123.

More about Influenza A H1N1 Virus

Open Document